Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 418 of 6351
-
New drug aims to shield autoimmune patients from Life-Threatening infections
Disease control Recruiting nowA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Panzyga for Prevention of Major Infection in Patients with Hypogammaglobulinemia and Autoimmune or Rheumatic Conditions Receiving Treatment with B-cell Depletion Therap…
Phase 3 • Sponsor: Octapharma • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New shot could help tame stubborn Graves' disease
Disease control Recruiting nowThe main purpose of this study is to look at how efgartigimod affects thyroid function in adults with Graves' Disease (GD). The study will also check whether efgartigimod is safe and well tolerated. It will look at how efgartigimod is distributed and eliminated in the body, how i…
Phase 3 • Sponsor: argenx • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Experimental CAR-T therapy targets tough childhood blood cancers
Disease control Not yet recruitingThis is a phase I, open-label, dose-escalation clinical trial. The primary objectives are to assess the safety of PA3-17 injection in pediatric and adolescent participants with relapsed/refractory T-lymphoblastic leukemia/lymphoma, and determine the recommended phase II dose of P…
Phase 1 • Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Last hope? new combo targets liver cancer that beat previous treatments
Disease control Recruiting nowThis is a prospective, single-arm, investigator-initiated clinical study designed to evaluate the safety and efficacy of lenalidomide in combination with targeted therapy and immunotherapy in patients with advanced hepatocellular carcinoma (HCC) who have experienced disease progr…
Phase 2 • Sponsor: Shunda Du • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Engineered immune cells take on tough leukemia in early trial
Disease control Recruiting nowThis single-arm, open-label phase I trial evaluates the safety and tolerability of ICG415, autologous CAR-T cells targeting CD33 and CLL1, in patients with relapsed or refractory acute myeloid leukemia (AML). Subjects receive lymphodepleting chemotherapy followed by autologous CA…
Phase 1 • Sponsor: iCell Gene Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Simple urine test could spot pancreatic cancer early
Diagnosis Recruiting nowThe main purpose of the study is to assess the performance of the Panuri test in detecting pancreatic ductal adenocarcinoma (PDAC) the most common type of pancreatic cancer that accounts for approximately 90% of all pancreatic cancer cases. The study aims to characterize the per…
Sponsor: Urteste S.A • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
Could a sprinkle of antibiotic powder in the ER prevent bone infections?
Disease control Not yet recruitingTo evaluate the feasibility, safety, and potential efficacy of applying vancomycin powder locally to open fractures in the emergency department prior to definitive surgical intervention.
Phase 3 • Sponsor: Atlantic Health System • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New monthly shot could help people with obesity shed pounds
Disease control Recruiting nowThe purpose of this clinical study is to learn about the effects and safety of berobenatide (PF-08653944). This may help people with overweight or obesity lose weight. People in this study may also have type 2 diabetes. About 950 adults will be in this study. Berobenatide will b…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Melatonin may double up against childhood migraines
Disease control By invitation onlyThis randomized controlled trial evaluated whether adding melatonin to propranolol provided better prevention of migraine in children than propranolol alone. The study included 60 children aged 5-15 years with migraine, diagnosed according to the International Classification of H…
Sponsor: Nishtar Medical University • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New drug delivery methods tested for tough breast cancer
Disease control Not yet recruitingAn Exploratory Study on the Efficacy and Safety of Different Administration Routes of SHR-A1811 in the Treatment of HER2-Positive Advanced Breast Cancer
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can a heart drug keep atrial fibrillation at bay after ablation?
Disease control Recruiting nowAtrial fibrillation (AF) is a common heart rhythm disorder associated with stroke, heart failure, and increased mortality. Catheter ablation with pulmonary vein isolation (PVI) is an effective rhythm-control strategy, but 20-30% of patients experience AF recurrence within one yea…
Phase 2 • Sponsor: National Cheng-Kung University Hospital • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug combo aims to keep childhood leukemia at bay after transplant
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of ASTX727 and filgrastim for the treatment of children with high risk acute myeloid leukemia that has come back after a period of improvement (recurrent) or that does not respond to treatment (refractory) who have …
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New combo pill aims to extend life in tough bile duct cancer
Disease control Recruiting nowThe object of this trial is to evaluate the efficacy of D07001-softgel capsules + capecitabine compared with placebo + capecitabine by overall survival (OS). Eligible patients with advanced biliary tract cancer (BTC) will be randomized (1:1:1) to receive either 60 mg D07001-soft…
Phase 3 • Sponsor: InnoPharmax Inc. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New program aims to stop depression before it starts in stressed teens
Prevention Not yet recruitingAmerican youth and young adults face persistent and chronic stressors, which have contributed to a mental health crisis in the United States. Four in 10 American high school students experience chronic feelings of sadness and hopelessness, 2 in 10 report suicidal ideation, and 1 …
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Prevention
Last updated Jun 27, 2026 12:24 UTC
-
Radiosurgery zaps cancer pain when opioids fail
Symptom relief Recruiting nowThe investigators propose to conduct a study in medically refractory cancer pain patients utilizing radiosurgery to ablate the pituitary hypophysis, as well as neuromodulate the centromedian and parafascicular complexes within the thalami - the so-called triple target. This invol…
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New combo therapy aims to personalize lung cancer treatment
Disease control Recruiting nowBackground: While third-generation EGFR tyrosine kinase inhibitors (TKI) like aumolertinib have significantly improved outcomes for patients with advanced lung adenocarcinoma, those harboring the L858R mutation still experience inferior prognosis compared to those with exon 19 de…
Phase 2 • Sponsor: Taipei Medical University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Engineered immune cells take on Hard-to-Treat cancers in early trial
Disease control Recruiting nowThe purpose of this study is to test the safety of MSK-TCR5 in participants with advance solid tumor cancer that has a KRAS, HRAS, or NRAS G12D mutation.
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Glowing dye may make pancreatic surgery safer
Disease control Recruiting nowPostoperative pancreatic fistula is the most important complication after laparoscopic distal pancreatectomy for tumors of the body and tail of the pancreas. It can cause infection, bleeding, longer hospital stay, and even death. New imaging technology using indocyanine green (IC…
Sponsor: Alexandria University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Tailor-Made vaccine aims to train immune system against cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and tolerability of ABO2109 in combination with toripalimab, and to evaluate the immunogenicity, pharmacokinetics, pharmacodynamics, as well as biomarker characteristics of the investigational cancer vaccine. In addition, the an…
Early phase 1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New drug combo aims to stop HPV head and neck cancer recurrence
Disease control Recruiting nowThe goal of this clinical trial is to learn if the combination of cemiplimab and fianlimab can improve outcomes compared to cemiplimab alone in adults with Human Papillomavirus Positive HPV-positive head and neck cancer who have detectable minimal-residual disease after definitiv…
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC